SARS-CoV-2 (COVID-19) Beta Variant ( B.1.351, SA) Spike RBD Recombinant Protein

SARS-CoV-2 (COVID-19) Spike RBD Recombinnat Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein

This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only.

All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. During the pandemic multiple mutant strains arose. To help the science combat these mutants ProSci offers the RB-Domains of these mutant SPIKE proteins. That is the full Receptor-Binding Domain of the SPIKE surface protein SARS-CoV-2 of the mutant strain B.1.351, also commonly known as the "SA / South Africa mutant".

not determined

20 mM Hepes pH 7.5; 150 mM NaCl

batch dependent

C-terminal His tag

43740568

surface glycoprotein

S

Severe acute respiratory syndrome coronavirus 2

Liquid

225 amino acids (including His tag); 25506 Da

>98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Indigo Agarose.

#N/A

HEK293 cells

P0DTC2